Coronavirus Disease (COVID-19) can be considered as a human pathological model of inflammation combined with hypoxia. In this setting, both erythropoiesis and iron metabolism appear to be profoundly affected by inflammatory and hypoxic stimuli, which act in the opposite direction on hepcidin regulation. The impact of low blood oxygen levels on erythropoiesis and iron metabolism in the context of human hypoxic disease (e.g., pneumonia) has not been fully elucidated. This multicentric observational study was aimed at investigating the prevalence of anemia, the alterations of iron homeostasis, and the relationship between inflammation, hypoxia, and erythropoietic parameters in a cohort of 481 COVID-19 patients admitted both to medical wards and intensive care units (ICU). Data were collected on admission and after 7 days of hospitalization. On admission, nearly half of the patients were anemic, displaying mild-to-moderate anemia. We found that hepcidin levels were increased during the whole period of observation. The patients with a higher burden of disease (i.e., those who needed intensive care treatment or had a more severe degree of hypoxia) showed lower hepcidin levels, despite having a more marked inflammatory pattern. Erythropoietin (EPO) levels were also lower in the ICU group on admission. After 7 days, EPO levels rose in the ICU group while they remained stable in the non-ICU group, reflecting that the initial hypoxic stimulus was stronger in the first group. These findings strengthen the hypothesis that, at least in the early phases, hypoxia-driven stimuli prevail over inflammation in the regulation of hepcidin and, finally, of erythropoiesis.

The role of hypoxia and inflammation in the regulation of iron metabolism and erythropoiesis in COVID-19: The IRONCOVID study / D. Maira, L. Duca, F. Busti, D. Consonni, M. Salvatici, A. Vianello, A. Milani, A. Guzzardella, E. Di Pierro, S. Aliberti, I.M. Baldini, A. Bandera, F. Blasi, E. Cassinerio, M. Cesari, A.L. Fracanzani, G. Grasselli, G. Graziadei, R. Lombardi, G. Marchi, N. Montano, V. Monzani, F. Peyvandi, M. Proietti, M. Sandri, L. Valenti, M.D. Cappellini, D. Girelli, A. Protti, I. Motta. - In: AMERICAN JOURNAL OF HEMATOLOGY. - ISSN 0361-8609. - 97:11(2022 Nov), pp. 1404-1412. [10.1002/ajh.26679]

The role of hypoxia and inflammation in the regulation of iron metabolism and erythropoiesis in COVID-19: The IRONCOVID study

D. Maira;L. Duca
Secondo
;
A. Vianello;A. Guzzardella;E. Di Pierro;S. Aliberti;A. Bandera;F. Blasi;M. Cesari;A.L. Fracanzani;G. Grasselli;G. Graziadei;R. Lombardi;N. Montano;V. Monzani;F. Peyvandi;M. Proietti;L. Valenti;M.D. Cappellini;A. Protti
Penultimo
;
I. Motta
Ultimo
2022

Abstract

Coronavirus Disease (COVID-19) can be considered as a human pathological model of inflammation combined with hypoxia. In this setting, both erythropoiesis and iron metabolism appear to be profoundly affected by inflammatory and hypoxic stimuli, which act in the opposite direction on hepcidin regulation. The impact of low blood oxygen levels on erythropoiesis and iron metabolism in the context of human hypoxic disease (e.g., pneumonia) has not been fully elucidated. This multicentric observational study was aimed at investigating the prevalence of anemia, the alterations of iron homeostasis, and the relationship between inflammation, hypoxia, and erythropoietic parameters in a cohort of 481 COVID-19 patients admitted both to medical wards and intensive care units (ICU). Data were collected on admission and after 7 days of hospitalization. On admission, nearly half of the patients were anemic, displaying mild-to-moderate anemia. We found that hepcidin levels were increased during the whole period of observation. The patients with a higher burden of disease (i.e., those who needed intensive care treatment or had a more severe degree of hypoxia) showed lower hepcidin levels, despite having a more marked inflammatory pattern. Erythropoietin (EPO) levels were also lower in the ICU group on admission. After 7 days, EPO levels rose in the ICU group while they remained stable in the non-ICU group, reflecting that the initial hypoxic stimulus was stronger in the first group. These findings strengthen the hypothesis that, at least in the early phases, hypoxia-driven stimuli prevail over inflammation in the regulation of hepcidin and, finally, of erythropoiesis.
Settore MED/09 - Medicina Interna
Settore MED/15 - Malattie del Sangue
5-lug-2022
Article (author)
File in questo prodotto:
File Dimensione Formato  
American J Hematol - 2022 - Maira - The role of hypoxia and inflammation in the regulation of iron metabolism and.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 1.91 MB
Formato Adobe PDF
1.91 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/937290
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact